Oncozenge AB (ONCOZ) — Financial Flexibility Index
Oncozenge AB (ONCOZ) has a Financial Flexibility Index of 0.37x as of December 2025. Free cash flow of Skr5.82 Million (operating CF Skr-7.24 Million minus capex Skr13.06 Million) represents 0% of total liabilities (Skr15.92 Million). Check ONCOZ cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncozenge AB Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Oncozenge AB across 6 annual periods. For the full cash flow conversion analysis, see ONCOZ cash flow conversion.
Annual Financial Flexibility Index for Oncozenge AB (2020–2025)
Year-by-year free cash flow to debt coverage for Oncozenge AB. Explore Oncozenge AB debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-13.06 Million | Skr15.92 Million | ▲ +100.0% |
| 2024 | -5.91x | Skr-8.76 Million | Skr-8.76 Million | Skr1.48 Million | ▲ +41.3% |
| 2023 | -10.05x | Skr-17.08 Million | Skr-17.08 Million | Skr1.70 Million | ▼ -33.0% |
| 2022 | -7.56x | Skr-22.08 Million | Skr-22.08 Million | Skr2.92 Million | ▼ -6395.2% |
| 2021 | 0.12x | Skr589.00K | Skr-4.77 Million | Skr4.90 Million | ▲ +108363.6% |
| 2020 | 0.00x | Skr-1.00K | Skr-1.00K | Skr9.01 Million | — |